Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inhibikase Therapeutics, Inc. (IKT) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Inhibikase Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1750149.
Total stock buying since 2021: $2,762,462.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $88,286.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 1,970,000 | $2,698,900 | 0 | $0 | 0 | $0 |
| 2022 | 23,948 | $17,422 | 0 | $0 | 21,853 | $44,143 |
| 2021 | 23,589 | $46,140 | 0 | $0 | 21,853 | $44,143 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-10 | 1,970,000 | $2,698,900 | 0 | $0 | 0 | $0 |
| 2022-08 | 5,000 | $4,000 | 0 | $0 | 0 | $0 |
| 2022-05 | 18,948 | $13,422 | 0 | $0 | 0 | $0 |
| 2022-01 | 0 | $0 | 0 | $0 | 21,853 | $44,143 |
| 2021-11 | 23,589 | $46,140 | 0 | $0 | 0 | $0 |
| 2021-08 | 0 | $0 | 0 | $0 | 21,853 | $44,143 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-10-21 | Kush Arvind | Buy | 145,000 | 1.37 | 198,650 |
| 2024-10-21 | Bellini Roberto | Buy | 1,460,000 | 1.37 | 2,000,200 |
| 2024-10-21 | Munshi Amit | Buy | 365,000 | 1.37 | 500,050 |
| 2022-08-16 | Werner Milton H. (President and CEO) | Buy | 5,000 | .80 | 4,000 |
| 2022-05-27 | Werner Milton H. (President and CEO) | Buy | 5,000 | .98 | 4,880 |
| 2022-05-20 | Werner Milton H. (President and CEO) | Buy | 10,000 | .60 | 6,000 |
| 2022-05-19 | Frattaroli Joseph (Chief Financial Officer) | Buy | 3,948 | .64 | 2,542 |
| 2022-01-03 | Werner Milton H. (President and CEO) | Option Ex | 21,853 | 2.02 | 44,143 |
| 2021-11-17 | Werner Milton H. (President and CEO) | Buy | 23,589 | 1.96 | 46,140 |
| 2021-08-17 | Werner Milton H. (President and CEO) | Option Ex | 21,853 | 2.02 | 44,143 |
Insider trading activities including stock purchases, stock sales, and option exercises of IKT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Inhibikase Therapeutics, Inc. (symbol IKT, CIK number 1750149) see the Securities and Exchange Commission (SEC) website.